Interstitial Lung Disease in Japanese Patients with Lung Cancer : A Cohort and Nested Case-Control StudyKUDOH, Shoji; KATO, Harubumi; HAIYI JIANG et al.American journal of respiratory and critical care medicine. 2008, Vol 177, Num 12, pp 1348-1357, issn 1073-449X, 10 p.Article

Phase III Study of Gefitinib 250 Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and NeckSTEWART, J. Simon W; COHEN, Ezra E. W; VARELLA-GARCIA, Marileila et al.Journal of clinical oncology. 2009, Vol 27, Num 11, pp 1864-1871, issn 0732-183X, 8 p.Article

Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients With Advanced Non-Small-Cell Lung Cancer and Poor Performance StatusGOSS, Glenwood; FERRY, David; ZARENDA, Marc et al.Journal of clinical oncology. 2009, Vol 27, Num 13, pp 2253-2260, issn 0732-183X, 8 p.Article

Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non―Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST TrialDOUILLARD, Jean-Yves; SHEPHERD, Frances A; WATKINS, Claire L et al.Journal of clinical oncology. 2010, Vol 28, Num 5, pp 744-752, issn 0732-183X, 9 p.Article

Gefitinib Versus Vinorelbine in Chemotherapy-Naive Elderly Patients With Advanced Non-Small-Cell Lung Cancer (INVITE) : A Randomized, Phase II StudyCRINO, Lucio; CAPPUZZO, Federico; DUFFIELD, Emma L et al.Journal of clinical oncology. 2008, Vol 26, Num 26, pp 4253-4260, issn 0732-183X, 8 p.Article

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non―Small-Cell Lung Cancer in Asia (IPASS)FUKUOKA, Masahiro; WU, Yi-Long; DUFFIELD, Emma L et al.Journal of clinical oncology. 2011, Vol 29, Num 21, pp 2866-2875, issn 0732-183X, 10 p.Article

Gefitinib or Carboplatin-Paclitaxel in Pulmonary AdenocarcinomaMOK, Tony S; WU, Yi-Long; NISHIWAKI, Yutaka et al.The New England journal of medicine. 2009, Vol 361, Num 10, pp 947-957, issn 0028-4793, 11 p.Article

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST) : a randomised phase III trial. CommentaryCULLEN, Michael; THATCHER, Nicholas; SELLERS, Mark V et al.Lancet (British edition). 2008, Vol 372, Num 9652, issn 0140-6736, 1785-1786, 1809-1818 [12 p.]Article